The coronary artery disease is a leading cause of death and morbidity worldwide. This disease has a complex pathophysiology that includes multiple mechanisms. Among these is the oxidative/nitrosative stress. Paradoxically, oxidative/nitrosative signaling plays a major role in cardioprotection against ischemia/reperfusion injury. In this context, the gas transmitter nitric oxide may act through several mechanisms, such as guanylyl cyclase activation and via S-nitrosylation of proteins. The latter is a covalent modification of a protein cysteine thiol by a nitric oxide-group that generates an S-nitrosothiol. Here, we report data showing that nitric oxide and S-nitrosylation of proteins play a pivotal role not only in preconditioning but also in postconditioning cardioprotection.
XiaCMisraIIyanagiTKimJJ. Regulation of interdomain interactions by calmodulin in inducible nitric-oxide synthase. J Biol Chem2009; 284: 30708–17.
8.
ZaobornyjTGhafourifarP. Strategic localization of heart mitochondrial NOS: a review of the evidence. Am J Physiol Heart Circ Physiol2012; 303: H1283–93.
9.
SunJMurphyE. Protein S-nitrosylation and cardioprotection. Circ Res2010; 106: 285–96.
10.
PagliaroPMoroFTullioFPerrelliMGPennaC. Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxid Redox Signal2011; 14: 833–50.
11.
BradyNRHamacher-BradyAWesterhoffHVGottliebRA. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal2006; 8: 1651–65.
12.
BainesCP. The mitochondrial permeability transition pore as a target of cardioprotective signaling. Am J Physiol Heart Circ Physiol2007; 293: H903–4.
13.
CostaADGarlidKD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol2008; 295: H874–82.
14.
DostTCohenMVDowneyJM. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol2008; 103: 378–84.
15.
BrownDIGriendlingKK. Nox proteins in signal transduction. Free Radic Biol Med2009; 47: 1239–53.
16.
ChenKCraigeSEKeaneyJFJr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal2009; 11: 2467–80.
17.
GarlidAOJaburekMJacobsJPGarlidKD. Mitochondrial reactive oxygen species – Which ROS signals cardioprotection?Am J Physiol Heart Circ Physiol2013; 305: H960–8.
18.
Martinez-RuizAAraujoIMIzquierdo-AlvarezAHernansanz-AgustinPLamasSSerradorJM. Specificity in S-Nitrosylation: a short-range mechanism for NO signaling?Antioxid Redox Signal2013; 19: 1220–35.
19.
MurryCEJenningsRBReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation1986; 74: 1124–36.
20.
PagliaroPGattulloDRastaldoRLosanoG. Ischemic preconditioning: from the first to the second window of protection. Life Sci2001; 69: 1–15.
21.
ZhaoZQCorveraJSHalkosMEKerendiFWangNPGuytonRAVinten-JohansenJ. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol2003; 285: H579–88.
22.
SkyschallyAVan CasterPIliodromitisEKSchulzRKremastinosDTHeuschG. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol2009; 104: 469–83.
23.
YellonDMDowneyJM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev2003; 83: 1113–51.
BoenglerKHeuschGSchulzR. Mitochondria in postconditioning. Antioxid Redox Signal2011; 14: 863–80.
26.
CohenMVDowneyJM. Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal2011; 14: 821–31.
27.
HausenloyDJLecourSYellonDM. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal2011; 14: 893–907.
28.
NakamuraTLiptonSA. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Antioxid Redox Signal2011; 14: 1479–92.
29.
BrownGCBorutaiteV. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta2004; 1658: 44–9.
SanthanamLLimHKLimHKMirielVBrownTPatelMBalansonSRyooSAndersonMIraniKKhandayFDi CostanzoLNyhanDHareJMChristiansonDWRiversRShoukasABerkowitzDE. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res2007; 101: 692–702.
32.
SipsPYIrieTZouLShinozakiSSakaiMShimizuNNguyenRStamlerJSChaoWKanekiMIchinoseF. Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression. Am J Physiol Heart Circ Physiol2013; 304: H1134–46.
33.
JonesSPBolliR. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol2006; 40: 16–23.
34.
AtarSYeYLinYFreebergSYNishiSPRosanioSHuangMHUretskyBFPerez-PoloJRBirnbaumY. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol2006; 290: H1960–8.
35.
HausenloyDJYellonDM. The second window of preconditioning (SWOP) where are we now?Cardiovasc Drugs Ther2010; 24: 235–54.
36.
BolliR. The late phase of preconditioning. Circ Res2000; 87: 972–83.
37.
BolliRDawnBTangXLQiuYPingPXuanYTJonesWKTakanoHGuoYZhangJ. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol1998; 93: 325–38.
38.
EspeyMGMirandaKMThomasDDXavierSCitrinDVitekMPWinkDA. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann N Y Acad Sci2002; 962: 195–206.
ZhangYYXuAMNomenMWalshMKeaneyJFJrLoscalzoJ. Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity. J Biol Chem1996; 271: 14271–9.
41.
WinkDADarbyshireJFNimsRWSaavedraJEFordPC. Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem Res Toxicol1993; 6: 23–7.
42.
ZouMMartinCUllrichV. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem1997; 378: 707–13.
43.
TurkoIVMuradF. Protein nitration in cardiovascular diseases. Pharmacol Rev2002; 54: 619–34.
44.
IschiropoulosH. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun2003; 305: 776–83.
45.
KupaiKCsonkaCFeketeVOdendaalLvan RooyenJMarais deWCsontTFerdinandyP. Cholesterol diet induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol2009; 297: H1729–35.
46.
LiJLoukiliNRosenblatt-VelinNPacherPFeihlFWaeberBLiaudetL. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PLoS One2013; 8: e70–e70.
47.
PennaCPerrelliMGTullioFMoroFParisellaMLMerlinoAPagliaroP. Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation. Pflugers Arch2011; 462: 219–33.
48.
YangYYLeeKCHuangYTWangYWHouMCLeeFYLinHCLeeSD. Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. J Hepatol2008; 49: 25–33.
49.
InserteJHernandoVVilardosaÚAbadEPoncelas-NozalMGarcia-DoradoD. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc2013; 2: e005975–e005975.
50.
StamlerJSTooneEJ. The decomposition of thionitrites. Curr Opin Chem Biol2002; 6: 779–85.
51.
HouYGuoZLiJWangPG. Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols. Biochem Biophys Res Commun1996; 228: 88–93.
52.
GrishamMB. Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys1999; 361: 323–30.
53.
Jourd’heuilDLarouxFSMilesAMWinkDAGrishamMB. Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys1999; 361: 323–30.
54.
SliskovicIRaturiAMutusB. Characterization of the S-denitrosation activity of protein disulfide isomerase. J Biol Chem2005; 280: 8733–41.
55.
BatemanRLRauhDTavshanjianBShokatKM. Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem2008; 283: 35756–62.
56.
BenharMForresterMTHessDTStamlerJS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science2008; 320: 1050–54.
57.
AnandPStamlerJS. Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. J Mol Med (Berl)2012; 90: 233–44.
SenguptaRRyterSWZuckerbraunBSTzengEBilliarTRStoyanovskyDA. Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. Biochemistry2007; 46: 8472–83.
60.
BenharMForresterMTStamlerJS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol2009; 10: 721–32.
61.
MelikianNSeddonMDCasadeiBChowienczykPJShahAM. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med2009; 19: 256–62.
62.
PagliaroP. Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. Life Sci2003; 73: 2137–49.
63.
HofmannFFeilRKleppischTSchlossmannJ. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev2006; 86: 1–23.
64.
FosterDBVan EykJEMarbánEO'RourkeB. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr2009; 41: 159–68.
65.
MurphyEKohrMSunJNguyenTSteenbergenC. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol2012; 52: 568–77.
66.
LiuXMillerMJSJoshiMSThomasDDLancasterJR. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA1998; 95: 2175–9.
67.
NedospasovARafikovRBedaNNudlerE. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci USA2000; 97: 13543–8.
68.
BurwellLSBrookesPS. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal2008; 10: 579–99.
69.
PacherPBeckmanJSLiaudetL. Nitric oxide and peroxynitrite in health and disease. Physiol Rev2007; 87: 315–424.
70.
IschiropoulosH. Protein tyrosine nitration—An update. Arch Biochem Biophys2009; 484: 117–21.
71.
FerdinandyPSchulzR. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol2003; 138: 532–43.
72.
EdingerALThompsonCB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol2004; 16: 663–9.
73.
GottliebRAFinleyKDMentzerRMJr. Cardioprotection requires taking out the trash. Basic Res Cardiol2009; 104: 169–80.
74.
GiriczZGörbeAPipisJBurleyDSFerdinandyPBaxterGF. Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats. Br J Pharmacol2009; 158: 1495–502.
75.
KohrMJAponteAMSunJWangGMurphyEGucekMSteenbergenC. Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol2011; 300: H1327–35.
76.
PiantadosiCA. Regulation of mitochondrial processes by protein S- nitrosylation. Biochim Biophys Acta2012; 1820: 712–21.
77.
BabaSPWetzelbergerKHoetkerJDBhatnagarA. Posttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation. Chem Biol Interact2009; 178: 250–8.
78.
LimaBForresterMTHessDTStamlerJS. S-nitrosylation in cardiovascular signaling. Circ Res2010; 106: 633–46.
79.
MaronBATangSSLoscalzoJ. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal2013; 18: 270–87.
80.
Aracena-ParksPGoonasekeraSAGilmanCPDirksenRTHidalgoCHamiltonSL. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem2006; 281: 40354–68.
81.
GonzalezDRTreuerAVCastellanosJDulceRAHareJM. Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. J Biol Chem2010; 285: 28938–45.
82.
EuJPSunJXuLStamlerJSMeissnerG. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell2000; 102: 499–509.
83.
AdachiTWeisbrodRMPimentelDRYingJSharovVSSchöneichCCohenRA. S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med2004; 10: 1200–7.
84.
SunJPichtEGinsburgKSBersDMSteenbergenCMurphyE. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res2006; 98: 403–11.
AsadaKKurokawaJFurukawaT. Redox-and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J Biol Chem2009; 284: 6014–20.
87.
LuXMLuMTompkinsRGFischmanAJ. Site-specific detection of S-nitrosylated PKB alpha/Akt1 from rat soleus muscle using CapLC-Q-TOF(micro) mass spectrometry. J Mass Spectrom2005; 40: 1140–8.
88.
KwakYDMaTDiaoSZhangXChenYHsuJLiptonSAMasliahEXuHLiaoFF. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol Neurodegener2010; 5: 49–49.
89.
Linares-PalominoJHusainyMALaiVKDickensonJMGaliñanesM. Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury. J Physiol2010; 588: 2173–91.
90.
StamlerJS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest2005; 115: 509–17.
91.
SunJSteenbergenCMurphyE. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal2006; 8: 1693–705.
92.
HareJMStamlerJS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest2005; 115: 509–17.
93.
Vinten-JohansenJGranfeldtAMykytenkoJUndyalaVVDongYPrzyklenkK. The multidimensional physiological responses to postconditioning. Antioxid Redox Signal2011; 14: 791–810.
94.
HausenloyDJErik BøtkerHCondorelliGFerdinandyPGarcia-DoradoDHeuschGLecourSvan LaakeLWMadonnaRRuiz-MeanaMSchulzRSluijterJPYellonDMOvizeM. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res2013; 98: 7–27.
95.
PennaCMancardiDRastaldoRPagliaroP. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta2009; 1787: 781–93.
96.
BurgoyneJREatonP. Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-adrenergic-like signaling. J Biol Chem2009; 284: 29260–8.
97.
LiXDChengYTYangYJMengXMZhaoJLZhangHTWuYJYouSJWuYL. PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow. Microvasc Res2012; 84: 44–54.
98.
EdwardsHVScottJDBaillieGS. PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects. Biochem Soc Trans2012; 40: 210–4.
99.
YangCTalukderMAVaradharajSVelayuthamMZweierJL. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation. Cardiovasc Res2013; 97: 33–43.
100.
WetzelbergerKBabaSPThirunavukkarasuMHoYSMaulikNBarskiOAConklinDJBhatnagarA. Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids. J Biol Chem2010; 285: 26135–48.
101.
ChenY-RChenC-LPfeifferDRZweierJL. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem2007; 282: 32640–54.
102.
DowneyJMCohenMV. Reducing infarct size in the setting of acute myocardial infarction. Prog Cardiovasc Dis2006; 48: 363–71.
103.
PerrelliMGPagliaroPPennaC. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol2011; 3: 186–200.
104.
StrasenJRitterO. Role of nNOS in cardiac ischemia-reperfusion injury. Trends Cardiovasc Med2011; 21: 58–63.
105.
CrisafulliAMelisFToccoFPittauGLorraiLGoriTMancardiDConcuAPagliaroP. Delayed preconditioning-mimetic actions of exercise or nitroglycerin do not affect haemodynamics and exercise performance in trained or sedentary individuals. J Sports Sci2007; 25: 1393–401.
106.
Vinten-JohansenJZhaoZQJiangRZattaAJ. Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther2005; 3: 1035–45.
107.
ZhaoZQVinten-JohansenJ. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res2006; 70: 200–11.
108.
YangXCohenMVDowneyJM. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther2010; 24: 225–34.
109.
OvizeMBaxterGFDi LisaFFerdinandyPGarcia-DoradoDHausenloyDJHeuschGVinten-JohansenJYellonDMSchulzRWorking Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res2010; 87: 406–23.
110.
SiegfriedMRErhardtJRiderTMaXLLeferAM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther1992; 260: 668–75.
111.
HillMTakanoHTangXLKodaniEShirkGBolliR. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation2001; 104: 694–9.
112.
PennaCAlloattiGCappelloSGattulloDBertaGMognettiBLosanoGPagliaroP. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol2005; 288: H2512–20.
113.
IliodromitisEKGaitanakiCLazouAAggeliIKGizasVBofilisEZogaABeisIKremastinosDT. Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning. Basic Res Cardiol2006; 101: 327–35.
114.
PennaCSettanniFTullioFTrovatoLPagliaroPAlloattiGGhigoEGranataR. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology2013; 154: 1624–35.
115.
PerrelliMGTullioFAngottiCCerraMCAngeloneTTotaBAlloattiGPennaCPagliaroP. Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling. Pflugers Arch2013; 465: 1031–40.
116.
HausenloyDJYellonDM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev2007; 12: 217–34.
117.
CohenMVDowneyJM. Cardioprotection: spotlight on PKG. Br J Pharmacol2007; 152: 833–4.
118.
HausenloyDJYellonDM. Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes Obes Metab2008; 10: 451–9.
119.
HausenloyDJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost2009; 101: 626–34.
120.
HausenloyDJOngSBYellonDM. The mitochondrial permeability transition pores as a target for preconditioning and postconditioning. Basic Res Cardiol2009; 104: 189–202.
121.
LecourS. Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?J Mol Cell Cardiol2009; 47: 32–40.
122.
LecourS. Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?J Mol Cell Cardiol2009; 46: 607–9.
123.
MancardiDPennaCMerlinoADel SoldatoPWinkDAPagliaroP. Physiological and pharmacological features of the novel gas-transmitter: hydrogen sulfide. Biochim Biophys Acta2009; 1787: 864–72.
124.
OzcanSAndraliSSCantrellJE. Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta2010; 1799: 353–64.
125.
FengXSunTBeiYDingSZhengWLuYShenP. S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis. Sci Rep2013; 3: 1814–1814.
126.
FiliceEAngeloneTDe FrancescoEMPellegrinoDMaggioliniMCerraMC. Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart. Cell Physiol Biochem2011; 28: 41–52.
127.
AngeloneTQuintieriAMPasquaTGentileSTotaBMahataSKCerraC. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Physiol Heart Circ Physiol2012; 302: H431–42.
128.
InserteJRuiz-MeanaMRodríguez-SinovasABarbaIGarcia-DoradoD. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. Antioxid Redox Signal2011; 14: 923–39.
129.
SunJMorganMShenRFSteenbergenCMurphyE. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetic and calcium transport. Circ Res2007; 101: 1155–63.
130.
MurphyESteenbergenC. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res2007; 75: 478–86.
131.
SunJKohrMJNguyenTAponteAMConnellyPSEsfahaniSGGucekMDanielsMPSteenbergenCMurphyE. Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid Redox Signal2012; 16: 45–56.
132.
PennaCBassinoEAlloattiG. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. Exp Biol Med (Maywood)2011; 236: 390–401.
133.
LotzCLiemDPingP. New frontiers in myocardial protection: a systems biology approach. J Cardiovasc Pharmacol Ther2011; 16: 285–9.
134.
KohrMJSunJAponteAWangGGucekMMurphyESteenbergenC. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/ reperfusion injury with resin-assisted capture. Circ Res2011; 108: 418–26.
135.
OkazakiTOtaniHShimazuTYoshiokaKFujitaMKatanoTItoSIwasakaT. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol2011; 50: 534–44.
136.
LinJSteenbergenCMurphyESunJ. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation2009; 120: 245–54.
137.
SunJ. Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning. Sheng Li Xue Bao2007; 59: 544–52.
138.
SawickiGJugduttBI. Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine reperfused myocardial infarction. Proteomics2007; 7: 2100–10.
139.
MurphyESteenbergenC. Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev2007; 12: 293–300.
140.
AsanumaHNakaiKSanadaSMinaminoTTakashimaSOgitaHFujitaMHirataAWakenoMTakahamaHKimJAsakuraMSakumaIKitabatakeAHoriMKomamuraKKitakazeM. S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. J Mol Cell Cardiol2007; 42: 924–30.
141.
CaiZYanLJ. Protein oxidative modifications: beneficial roles in disease and health. J Biochem Pharmacol Res2013; 1: 15–26.
142.
MurrayCIChungHSUhrigshardtHVan EykJE. Quantification of mitochondrial S-nitrosylation by CysTMT6 switch assay. Methods Mol Biol2013; 1005: 169–79.
143.
MurrayCIVan EykJE. A twist on quantification: measuring the site occupancy of S-nitrosylation. Circ Res2012; 111: 1253–5.
144.
SchulzRFerdinandyP. Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activation. Free Radic Biol Med2013; 54: 113–5.
145.
KohrMJAponteASunJGucekMSteenbergenCMurphyE. Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication. Circ Res2012; 111: 1308–12.
LinYFRaab-GrahamKJanYNJanLY. NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc Natl Acad Sci USA2004; 101: 7799–804.
148.
AndohTLeeSYChiuehCC. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J2000; 14: 2144–6.
149.
PennaCPerrelliMGTullioFAngottiCCamporealeAPoliVPagliaroP. Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. Basic Res Cardiol2013; 108: 371–371.
150.
MethnerCLukowskiRGrubeKLogaFSmithRAMurphyMPHofmannFKriegT. Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G. Basic Res Cardiol2013; 108: 337–337.
151.
NadtochiySMBurwellLSBrookesPS. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J Mol Cell Cardiol2007; 42: 812–25.
152.
PrimeTABlaikieFHEvansCNadtochiySMJamesAMDahmCCVitturiDAPatelRPHileyCRAbakumovaIRequejoRChouchaniETHurdTRGarveyJFTaylorCTBrookesPSSmithRAMurphyMP. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci USA2009; 106: 10764–9.
153.
ChouchaniETHurdTRNadtochiySMBrookesPSFearnleyIMLilleyKSSmithRAMurphyMP. Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J2010; 430: 49–59.
154.
SunJAponteAMKohrMJTongGSteenbergenCMurphyE. Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling?Free Radic Biol Med2013; 54: 105–12.
155.
BaruaAStandenNBGaliñanesM. Dual role of nNOS in ischemic injury and preconditioning. BMC Physiol2010; 10: 15–15.
156.
CohenMVYangX-MDowneyJM. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct sparing strategies. Cardiovasc Res2006; 70: 231–9.
157.
GuoYLiQWuW-JTanWZhuXMuJBolliR. Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. J Mol Cell Cardiol2008; 44: 496–501.
158.
OldenburgOQinQKriegTYangX-MPhilippSCritzSDCohenMVDowneyJM. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol2004; 286: H468–76.
159.
BellRMYellonDM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res2001; 52: 274–80.
160.
ShivaSSackMNGreerJJDuranskiMRingwoodLABurwellLWangXMacArthurPHShojaARaghavachariNCalvertJWBrookesPSLeferDJGladwinMT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med2007; 204: 2089–102.
161.
GonzálezDRFernándezICOrdenesPPTreuerAVEllerGBoricMP. Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide2008; 18: 157–67.
QuinlanCLCostaADCostaCLPierreSVDos SantosPGarlidKD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol2008; 295: H953–61.
164.
TangZSchererPEOkamotoTSongKChuCKohtzDSNishimotoILodishHFLisantiMP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem1996; 271: 2255–61.
165.
PennaCPerrelliMGPagliaroP. Mitochondrial pathways, permeabilità transition pore, and redox signaling in cardioprotection: therapeutic implications. Antioxid Redox Signal2013; 18: 556–99.
166.
MurphyESteenbergenC. Preconditioning: the mitochondrial connection. Annu Rev Physiol2007; 69: 51–67.
167.
KriegTLiuYRützTMethnerCYangXMDostTFelixSBStaschJPCohenMVDowneyJM. BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts. Eur Heart J2009; 30: 1607–13.
168.
SalloumFNDasASamiduraiAHokeNNChauVQOckailiRAStaschJPKukrejaRC. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol2012; 302: H1347–54.
169.
RadovitsTKorkmazSMiesel-GröschelCSeidelBStaschJPMerkelyBKarckMSzabóG. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass. Eur J Cardiothorac Surg2011; 39: 248–55.
170.
PennaCCappelloSMancardiDRaimondoSRastaldoRGattulloDLosanoGPagliaroP. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol2006; 101: 168–79.
171.
InserteJBarbaIPoncelas-NozalMHernandoVAgullóLRuiz-MeanaMGarcia-DoradoD. cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. J Mol Cell Cardiol2011; 50: 903–9.
172.
PennaCPagliaroPRastaldoRDi PancrazioFLippeGGattulloDMancardiDSamajaMLosanoGMavelliI. F0F1 ATP synthase activity is differently modulated by coronary reactive hyperemia before and after ischemic preconditioning in the goat. Am J Physiol Heart Circ Physiol2004; 287: H2192–200.
173.
NguyenTTStevensMVKohrMSteenbergenCSackMNMurphyE. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem2011; 286: 40184–92.
174.
EuJPHareJMHessDTSkafMSunJCardenas-NavinaISunQADewhirstMMeissnerGStamlerJS. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci USA2003; 100: 15229–34.
175.
EuJPSunJXuLStamlerJSMeissnerG. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell2000; 102: 499–509.
176.
XuLEuJPMeissnerGStamlerJS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science1998; 279: 234–37.
177.
SteinbergSF. Oxidative stress and sarcomeric proteins. Circ Res2013; 112: 393–405.
178.
GonzalezDRTreuerASunQAStamlerJSHareJM. S-Nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol2009; 54: 188–95.
179.
Garcia-DoradoDRuiz-MeanaMInserteJRodriguez-SinovasAPiperHM. Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res2012; 94: 168–80.
180.
SukoJDrobnyHHellmannG. Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings. Biochim Biophys Acta1999; 1451: 271–87.
181.
CheongETumbevVAbramsonJSalamaGStoyanovskyDA. Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium2005; 37: 87–96.
182.
CheongETumbevVStoyanovskyDSalamaG. Effects of pO(2) on the activation of skeletal muscle ryanodine receptors by NO, A cautionary note. Cell Calcium2005; 38: 481–8.
183.
HartJDDulhuntyAF. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J Membr Biol2000; 173: 227–336.
184.
SunJYamaguchiNXuLEuJPStamlerJSMeissnerG. Regulation of the cardiac muscle ryanodine receptor by O2 tension and S-nitrosoglutathione. Biochemistry2008; 47: 13985–90.
185.
TocchettiCGWangWFroehlichJPHukeSAonMAWilsonGMDi BenedettoGO'RourkeBGaoWDWinkDAToscanoJPZaccoloMBersDMValdiviaHHChengHKassDAPaolocciN. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res2007; 100: 96–104.
186.
PagliaroPMancardiDRastaldoRPennaCGattulloDMirandaKMFeelischMWinkDAKassDAPaolocciN. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med2003; 34: 33–43.
187.
CampbellDLStamlerJSStraussHC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol1996; 108: 277–93.
188.
HuHChiamvimonvatNYamagishiTMarbanE. Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors. Circ Res1997; 81: 742–52.
189.
PoteserMRomaninCSchreibmayerWMayerBGroschnerK. S-nitrosation controls gating and conductance of the alpha 1 subunit of class C L-type Ca(2+) channels. J Biol Chem2001; 276: 14797–803.
190.
LearyPJRajasekaranSMorrisonRRTuomanenEIChinTKHofmannPA. A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. Am J Physiol Heart Circ Physiol2008; 294: H2775–84.
191.
Del MonteFLebecheDGuerreroJLTsujiTDoyeAAGwathmeyJKHajjarRJ. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci USA2004; 101: 5622–7.
192.
ZucchiRRoncaFRonca-TestoniS. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection?Pharmacol Ther2001; 89: 47–65.
193.
FosterDBO'RourkeBVan EykJE. What can mitochondrial proteomics tell us about cardioprotection afforded by preconditioning?Expert Rev Proteomics2008; 5: 633–6.
194.
GalkinAMoncadaS. S-nitrosation of mitochondrial complex I depends on its structural conformation. J Biol Chem2007; 282: 37448–53.
195.
HeuschGBoenglerKSchulzR. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol2010; 105: 151–4.
196.
MartinCSchulzRPostHBoenglerKKelmMKleinbongardPGresPSkyschallyAKonietzkaIHeuschG. Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res2007; 74: 46–55.
197.
GranfeldtALeferDJVinten-JohansenJ. Protective ischemia in patients: preconditioning and postconditioning. Cardiovasc Res2009; 83: 234–46.
198.
PennaCRastaldoRMancardiDRaimondoSCappelloSGattulloDLosanoGPagliaroP. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol2006; 101: 180–9..
199.
ZattaAJKinHLeeGWangNJiangRLustRReevesJGMykytenkoJGuytonRAZhaoZQVinten-JohansenJ. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res2006; 70: 315–24.
200.
KunoACritzSDCohenMVDowneyJM. Nicorandil opens mitochondrial K(ATP) channels not only directly but also through a NO-PKG-dependent pathway. Basic Res Cardiol2007; 102: 73–9.
201.
FosterDBHoASRuckerJGarlidAOChenLSidorAGarlidKDO’RourkeB. Mitochondrial ROMK channel is a molecular component of mitoK(ATP). Circ Res2012; 111: 446–54.
202.
SainiHKMachackovaJDhallaNS. Role of reactive oxygen species in ischemic preconditioning of subcellular organelles in the heart. Antioxid Redox Signal2004; 6: 393–404.
203.
BoenglerKKonietzkaIBuechertAHeinenYGarcia-DoradoDHeuschGSchulzR. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol2007; 292: H1764–9.
204.
Rodriguez-SinovasABoenglerKCabestreroAGresPMorenteMRuiz-MeanaMKonietzkaIMiróETotzeckAHeuschGSchulzRGarcia-DoradoD. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res2006; 99: 93–101.
205.
SánchezJARodríguez-SinovasABarbaIMiró-CasasEFernández-SanzCRuiz-MeanaMAlburquerque-BéjarJJGarcía-DoradoD. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Basic Res Cardiol2013; 108: 351–351.
206.
ChouchaniETMethnerCNadtochiySMLoganAPellVRDingSJamesAMCocheméHMReinholdJLilleyKSPartridgeLFearnleyIMRobinsonAJHartleyRCSmithRAKriegTBrookesPSMurphyMP. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med2013; 19: 753–9.
207.
JamesAMSharpleyMSManasARFrermanFEHirstJSmithRAMurphyMP. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem2007; 282: 14708–18.
208.
ZimaAVBlatterLA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res2006; 71: 310–21.
209.
SchulmanIHHareJM. Regulation of cardiovascular cellular processes by S-nitrosylation. Biochim Biophys Acta2012; 1820: 752–62.
210.
PennaCMancardiDRaimondoSGeunaSPagliaroP. The paradigm of postconditioning to protect the heart. J Cell Mol Med2008; 12: 435–58.
211.
IliodromitisEKAndreadouIProkovasEZogaAFarmakisDFotopoulouTIoannidisKParaskevaidisIAKremastinosDT. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol2010; 105: 193–203.
212.
FanQYangXCLiuYWangLFLiuSHGeYGChenMLWangWZhangLKIrwinMGXiaZ. Postconditioning attenuates myocardial injury by reducing nitro oxidative stress in vivo in rats and in humans. Clin Sci (Lond)2010; 120: 251–61.
